Matches in Wikidata for { <http://www.wikidata.org/entity/Q79546631> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q79546631 description "article scientifique (publié 2007)" @default.
- Q79546631 description "artikull shkencor i botuar më 01 janar 2007" @default.
- Q79546631 description "artículu científicu espublizáu en xineru de 2007" @default.
- Q79546631 description "im Januar 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79546631 description "scientific article published on 01 January 2007" @default.
- Q79546631 description "wetenschappelijk artikel" @default.
- Q79546631 description "наукова стаття, опублікована в січні 2007" @default.
- Q79546631 name "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 name "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 name "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 type Item @default.
- Q79546631 label "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 label "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 label "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 prefLabel "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 prefLabel "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 prefLabel "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 P1433 Q79546631-F6EF207B-1BB8-4B4A-95FB-5CBE92026B3B @default.
- Q79546631 P1476 Q79546631-B0A2058B-2BF4-4011-B1BC-C821CF985620 @default.
- Q79546631 P2093 Q79546631-047F7C18-DB80-422F-9519-143203E5592A @default.
- Q79546631 P2093 Q79546631-349BD7EE-3BCC-423F-A655-B98ED05404F4 @default.
- Q79546631 P2093 Q79546631-5C10E129-8251-4DE5-9BD3-6795DF32E39C @default.
- Q79546631 P2093 Q79546631-75E9CB63-7F5D-4A2C-9595-308D7038DEEF @default.
- Q79546631 P2093 Q79546631-88035623-200C-4F77-8B63-63250D63B887 @default.
- Q79546631 P2093 Q79546631-C4246E16-7FDD-40E4-8E13-84407AC3B1FA @default.
- Q79546631 P2093 Q79546631-E80E1DA6-7AD2-47DD-8B84-BDAFE0E24B43 @default.
- Q79546631 P2093 Q79546631-F7A1CF57-66A4-48D5-9902-51ADCABBAB0A @default.
- Q79546631 P304 Q79546631-431E8625-B886-48C6-8B8E-EC576B35E4F5 @default.
- Q79546631 P31 Q79546631-6846867C-CD85-4FA2-8DB5-42AF2897E279 @default.
- Q79546631 P356 Q79546631-4C3058E5-8CA2-4D78-B04A-C6D9BCFCE248 @default.
- Q79546631 P433 Q79546631-B6AA5B2A-4D96-43BF-9ABE-33BD380080FC @default.
- Q79546631 P478 Q79546631-1B977D7E-536D-4527-9894-56851FCCE570 @default.
- Q79546631 P50 Q79546631-8E120515-8FDE-4EA5-87F0-5F4C621510AD @default.
- Q79546631 P50 Q79546631-9D65DE89-6E5F-4508-B6E3-FD42AF0B0BC9 @default.
- Q79546631 P50 Q79546631-BE37589D-7A68-4F6A-AF58-D235B450C4F2 @default.
- Q79546631 P50 Q79546631-C1B9BA97-21EF-4140-BB2B-FEED9152A224 @default.
- Q79546631 P577 Q79546631-A24CE0B3-5067-49BD-9313-494E91D33E79 @default.
- Q79546631 P698 Q79546631-FD7C81B8-1F51-4AB6-B918-647A86F43F3F @default.
- Q79546631 P921 Q79546631-092A8030-4AD5-410E-A89A-08F9444FB8B0 @default.
- Q79546631 P921 Q79546631-11A4020A-0D79-4D65-9069-4A1E7AF8773A @default.
- Q79546631 P921 Q79546631-67DCED40-3A1B-49EE-87B6-4F4A0FFED32D @default.
- Q79546631 P356 EJE.1.02325 @default.
- Q79546631 P698 17218723 @default.
- Q79546631 P1433 Q3060778 @default.
- Q79546631 P1476 "Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study" @default.
- Q79546631 P2093 "Clara Sina" @default.
- Q79546631 P2093 "Claudio Guastella" @default.
- Q79546631 P2093 "Davide Dazzi" @default.
- Q79546631 P2093 "Guia Vannucchi" @default.
- Q79546631 P2093 "Paola Bonara" @default.
- Q79546631 P2093 "Roberto Ratiglia" @default.
- Q79546631 P2093 "Simona Simonetta" @default.
- Q79546631 P2093 "Stefania Rossi" @default.
- Q79546631 P304 "33-40" @default.
- Q79546631 P31 Q13442814 @default.
- Q79546631 P356 "10.1530/EJE.1.02325" @default.
- Q79546631 P433 "1" @default.
- Q79546631 P478 "156" @default.
- Q79546631 P50 Q44463239 @default.
- Q79546631 P50 Q46152118 @default.
- Q79546631 P50 Q59548561 @default.
- Q79546631 P50 Q60311689 @default.
- Q79546631 P577 "2007-01-01T00:00:00Z" @default.
- Q79546631 P698 "17218723" @default.
- Q79546631 P921 Q412323 @default.
- Q79546631 P921 Q422248 @default.
- Q79546631 P921 Q50357588 @default.